
Back to Nature: Prescription Dietary Supplements Cash in on Cholesterol R&D Setbacks
The Players Who Will Shape Health Care Reform in 2009

Branded for Failure? Industry Hesitant to Adopt FDA Brand Name Review Pilot
Reinforcements at Last: CDER Hiring Process Well Underway

Medicare Market Shares: Why the Big Plans Don’t Mind Losing Ground

Novartis Bets Big on Meningitis: Wall Street Awaits Blockbuster Vaccine Franchise

The First 100 Days: FDA’s Frank Torti Outlines His Vision for the Agency

Health Policy Players You Should Get To Know
